Authors
Loading...
Findings reveal that DAPK1 modulates parkin activity, leading to increased toxicity in neurodegenerative conditions.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: